当前位置: 首页 > 期刊 > 《中国现代医生》 > 20203
编号:13514929
自噬调节EMT过程在间质性肺病中的作用机制探讨(5)
http://www.100md.com 2020年1月25日 《中国现代医生》 20203
     [16] Jiao L,Zhang HL,Li DD,et al. Regulation of glycolytic metabolism by autophagy in liver cancer involves selective autophagic degradation of HK2(hexokinase 2)[J]. Autophagy,2018,14(4):671-684.

    [17] Mi S,Li Z,Yang HZ,et al. Blocking IL-17A promotes the resolution of pulmonary inflammation and fibrosis via TGF-beta1-dependent and -independent mechanisms[J]. J Immunol,2015,187(6):3003-3014.

    [18] Kuwano K,Araya J,Hara H,et al. Cellular senescence and autophagy in the pathogenesis of chronic obstructive pulmonary disease(COPD) and idiopathic pulmonary fibrosis(IPF)[J]. Respir Investig,2016,54(6):397-406.

    [19] Noble PW,Albera C,Bradford WZ,et al. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY):Two randomised trials[J]. Lancet,2014,377(9779):1760-1769.

    [20] Azuma A,TaguchiY,Ogura T,et al. Exploratory analysis of a phase III trial of pirfenidone identifies a subpopulation of patients with idiopathic pulmonary fibrosis as benefiting from treatment[J]. Respir Res,2014,12:143.

    [21] Koesters R,Kaissling B,LehirM,et al. Tubular overexpression of transforming growth factor-beta1 induces autophagy and fibrosis but not mesenchymal transition of renal epithelial cells[J]. Am J Pathol,2014,177(2):632-643.

    (收稿日期:2019-04-15), 百拇医药(徐存来 潘炯伟 金元虹)
上一页1 2 3 4 5